Journal article icon

Journal article

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.

Abstract:

BACKGROUND: New vaccines to prevent tuberculosis are urgently needed. MVA85A is a novel viral vector TB vaccine candidate designed to boost BCG-induced immunity when delivered intradermally. To date, intramuscular delivery has not been evaluated. Skin and muscle have distinct anatomical and immunological properties which could impact upon vaccine-mediated cellular immunity. METHODS: We conducted a randomised phase I trial comparing the safety and immunogenicity of 1×10(8)pfu MVA85A delivered ...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
Vaccine
Volume:
31
Issue:
7
Pages:
1026-1033
Publication date:
2013-02-01
DOI:
EISSN:
1873-2518
ISSN:
0264-410X
Source identifiers:
369852

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP